Friday, Sep 22, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Lethal Neocov May Kill 1 In 3 Warn Wuhan Scientists

Lethal ‘NeoCov’ may kill 1 in 3, warn Wuhan scientists

Beijing: Wuhan is back in the news as a team of scientists have warned of a lethal variant called ‘NeoCov’ that requires only one mutation to infiltrate human cells and carries the combination of Middle East Respiratory Syndrome coronavirus (MERS)-CoV mortality rate (where one in every three infected persons may die) and the current SARS-CoV-2 […]

By IANS
Updated On - 07:47 PM, Fri - 28 January 22
Lethal ‘NeoCov’ may kill 1 in 3, warn Wuhan scientists
Representational image
whatsapp facebook twitter telegram

Beijing: Wuhan is back in the news as a team of scientists have warned of a lethal variant called ‘NeoCov’ that requires only one mutation to infiltrate human cells and carries the combination of Middle East Respiratory Syndrome coronavirus (MERS)-CoV mortality rate (where one in every three infected persons may die) and the current SARS-CoV-2 coronavirus high transmission rate. According to the scientists from Wuhan University in China, NeoCov can penetrate human cells in the same way as the SARS-CoV-2 virus.
“It is only one mutation away from becoming dangerous for humans,” researchers said in a paper posted on preprint website bioRxiv which has not been peer-reviewed yet. NeoCoV has been discovered among bats in South Africa and has only been known to spread among these animals to date. The MERS-CoV and several bat coronaviruses employ ‘DPP4’ as their functional receptors.

However, the receptor for NeoCoV, the closest MERS-CoV relative yet discovered in bats, remains ‘enigmatic’. In the study, the researchers unexpectedly found that NeoCoV and its close relative, PDF-2180-CoV, can efficiently use some types of bat Angiotensin-converting enzyme 2 (ACE2) and, less favourably, human ACE2 for entry. “NeoCoV efficiently infects human ACE2 expressing cells after a T510F mutation on the receptor-binding motif (RBM). Notably, the infection could not be cross-neutralised by antibodies targeting SARS-CoV-2 or MERS-CoV,” the study showed.

It means that neither antibodies nor protein molecules produced by people with respiratory diseases or who have been fully vaccinated can protect against NeoCoV. The study demonstrated the first case of ACE2 usage in MERS-related viruses, shedding light on a potential bio-safety threat of the human emergence of an ACE2 using ‘MERS-CoV-2’ with both high fatality and transmission rate.

Associated with the MERS-CoV virus, the new virus was discovered in outbreaks in Middle Eastern countries in 2012 and 2015 and is similar to SARS-CoV-2, which causes Covid in humans. Its impact on humans is yet to be ascertained. According to the World Health Organisation (WHO), whether NeoCov coronavirus poses a threat to humans requires further study. The WHO has said that it ‘works closely’ with the World Organisation for Animal Health (OIE), the Food and Agriculture Organisation (FAO) and the UN Environment Programme (UNEP) in order to “monitor and respond to the threat of emerging zoonotic viruses”.

Since the beginning of the Covid pandemic that has its origin in Wuhan, the SARS-CoV-2 coronavirus that causes Covid-19, has mutated and resulted in different variants of the virus, including the latest Omicron. The Delta strain is regarded as the most contagious form of the SARS-CoV-2 coronavirus to date.

Also read

NeoCov’s potential danger to humans requires further study: WHO

 

Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • coronavirus (MERS)
  • NeoCov
  • NeoCov coronavirus
  • SARS-CoV-2 virus

Related News

  • Do not panic over NeoCov, say Doctors

    Do not panic over NeoCov, say Doctors

  • NeoCov’s potential danger to humans requires further study: WHO

    NeoCov’s potential danger to humans requires further study: WHO

  • Molnupiravir has no observed safety concerns: MSD India

    Molnupiravir has no observed safety concerns: MSD India

  • Scientists developing chewing gum that could cut Covid transmission

    Scientists developing chewing gum that could cut Covid transmission

  • Telangana keeps Covid in check

    Telangana keeps Covid in check

  • Oravax inks pact with Premas Biotech for injectable vaccine technology

    Oravax inks pact with Premas Biotech for injectable vaccine technology

Latest News

  • BRS Leader Kavitha applauds Women’s Reservation Bill passage in Parliament

    2 mins ago
  • G4 nations call for UNSC expansion; support each other’s candidature

    7 mins ago
  • Raghav Chadha and Parineeti Chopra head to Udaipur for wedding

    13 mins ago
  • Leverkusen ease past BK Hacken in UEFA Europa League

    17 mins ago
  • Exercise was to create poll issue without implementing it: Cong after passage of women’s reservation bill

    22 mins ago
  • Google Introduces AI-Powered Coding Assistant Studio Bot in India”

    23 mins ago
  • Biden hosts Zelenskyy at White House; announces new military aid package for Ukraine

    32 mins ago
  • iPhone 15 series draws long queues in Mumbai stores on launch day

    29 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam